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Abstract  
Introduction: The rising prevalence of chronic kidney disease (CKD) remains a global public health challenge particularly in developing countries, 
including our local environment, where subjects with the disease present late and may already be in need of renal replacement therapy. Early 
detection of modifiable risk factors of CKD is a plausible strategy to reduce its prevalence and burden. The 2014 World Kidney Day (WKD) exercise 
provided a veritable opportunity to identify CKD risk factors among adult Nigerians for early intervention. Methods: Subjects were mobilized from 
the University community for the 2014 WKD exercise. The parameters assessed were demographics, Body mass index (BMI), blood pressures, 
proteinuria, glycosuria, serum creatinine and fasting plasma glucose. Glomerular Filtration Rate (GFR) was estimated using the Cockcroft-Gault 
equation. Data were analyzed using SPSS version 17.0. Results: A total of 259 volunteers were studied, mean age of 28.3±9.7years (16-66years). 
Males comprised 135(52.1%) while 124(47.9%) were females. The frequency of risk factors of CKD observed were obesity in 31(12.2%) subjects, 
proteinuria and glycosuria in 32(12.4%) and 7(2.7%) subjects respectively. Hypertension and hyperglycaemia were seen in 54(20.8%) and 
11(4.3%) of subjects respectively. Five subjects (1.9%) had e-GFR < 60mls/min/1.73m2. Conclusion: Prevalence of CKD risk factors in this study 
population was high. There is need for continuous education, regular screening for early detection and early intervention by risk factor modification 
to prevent and/or reduce the growing burden of CKD and its sequelae in Nigeria. 
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Chronic kidney disease (CKD) has become a major health concern 
globally, especially in developing countries with a marked burden in 
Sub-Saharan Africa [1]. This concern is largely due to the rising 
prevalence of risk factors such as type 2 diabetes, hypertension, 
and the HIV pandemic, the enormous cost implication of its 
treatment, its role in cardiovascular morbidity and mortality and the 
fact that the disease largely afflicts the economically productive 
younger age groups [1,2]. Several hospital based studies in Nigeria 
have put the prevalence of CKD between 1.6 - 12.4% [3] with a 
high prevalence of risk factors observed in various studies among 
different groups [4,5]. The early stages of CKD (stages 1-3a) are 
generally asymptomatic; therefore, the burden of the disease at 
these early stages goes largely undetected and difficult to assess. 
The symptoms only begin to manifest when greater than fifty 
percent of renal functional mass has been lost [6]. Most patients 
therefore present late to hospital, usually in the advanced diseased 
states and in need of salvage dialysis. As a result therefore, regular 
screening to aid early detection of risk factors is paramount in the 
prevention of CKD and ESRD. This need cannot be over-
emphasized. The aim of this study was to determine the prevalence 
of risk factors for CKD among adults in a University community in 
the South-South Region of Nigeria, for early intervention in 





This was a cross-sectional cohort study of adult volunteers in a 
University in the South-South region of Nigeria during the 2014 
World kidney day exercise. Subjects for the study were mobilized 
through the University authorities. Verbal informed consent was 
obtained from each of the participants after a session of health 
education on kidney health. The study participants included 
consultant nephrologists, residents in internal medicine, house 
officers, medical students, and nephrology nurses, all of whom 
participated in data collection.  
  
Clinical evaluation  
  
Demographic data were obtained through interviewer-administered 
questionnaires and included age, sex, family and personal history of 
hypertension, diabetes and kidney disease. Pregnant women and 
individual with acute febrile illness were excluded from the study. 
Weight was measured with a standard measuring scale calibrated in 
kilograms with subjects standing erect, bare-foot, and without 
heavy clothing. Height was measured with a standiometer with 
subjects standing feet together without shoes or head gear. Body 
mass index (BMI) was calculated as body weight in kilograms 
divided by the square of the height in meters. Obesity was defined 
as BMI≥ 30kg/m² according to the WHO guidelines [7]. Blood 
pressure was measured with a standard (Accosson) mercury 
sphygmomanometer on the patients' right arm in the seated 
position with feet on the floor after at least a five-minute rest. 
Systolic and diastolic blood pressures were taken at Korotkoff 
phases 1 and 5 respectively to the nearest 2 mmHg. The average of 
two blood pressure measurements taken five minutes apart was 
used. Hypertension was defined as SBP≥140mmHg and /or 
DBP≥90mmHg [8]. Elevated SBP was defined as SBP≥140mmHg 
and elevated DBP as DBP≥90mmHg.  
  
Biochemical analysis  
  
A sample of five millimetres (5mls) of venous blood was taken from 
each subject for assessment of serum creatinine. The samples were 
placed in lithium heparin bottles (gently mixed) and transported 
immediately to the chemical pathology laboratory. Proteinuria and 
glycosuria were assessed in subjects' urine using combi-2 dipstick. 
Proteinuria and glycosuria were defined as the presence of at least 
1+ of protein and 1+ of glucose on dipstick respectively. Random 
blood sugar was measured using the Accucheck Glucometer, and 
results were expressed in mmol/l. Hyperglycaemia was defined as 
random blood sugar > 11.1mmol/l (>200mg/dl). The Glomerular 
filtration rate was estimated using the Cockcroft-Gault equation [9] 
with correction for body surface area (BSA). Body surface area was 
calculated using the DuBois and DuBois formula [10].  
  
Statistical analysis  
  
Collated data were analysed using statistical package for social 
sciences (SPSS) version 17.0 analytic software. Continuous variables 
were compared with the independent samples T-test and the Chi-
square test was used to compare categorical variables. Pearson 





Demographic and clinical characteristics of subjects:  
  
A total of 259 subjects were screened for CKD in this study. The 
mean age of subjects in the study was 28.3±9.7 years with a range 
of 16 to 66years. Majority of the study population 235(90.7%) were 
less than 45 years, 23(8.9%) were between 45 years and 65 years. 
Only one subject (0.4%) was over 65 years. There were more males 
than females, 135 (52.1%) and 124 (47.9%) respectively. Personal 
history of hypertension, diabetes and CKD was obtained in 
10(3.9%), 5(1.9%) and 4(1.5%) subjects respectively. Family 
history of hypertension and diabetes was obtained in 87(33.6%) 
and 66(25.5%) of subjects respectively and only 4(1.5%) subjects 
had a family history of CKD.  
  
Clinical characteristics of study group  
  
The weight in kilograms was significantly higher among the male 
subjects, though no statistical significant difference was observed in 
the BMI among the male and female subjects. The systolic and 
diastolic blood pressures were higher the male population, with a 
lower eGFR observed among the female population. These results 
were statistically significant. The clinical characteristics of the study 
group are shown in Table 1.  
  
Frequency of risk factors for CKD  
  
Hypertension was observed in 20.8% of subjects, 12.2% of subjects 
were obese and 4.3% had hyperglycaemia. The eGFR was less than 
60mls/min/1.73m2 in 1.9% of subjects. The frequency of risk factors 
for CKD are shown in Figure 1. There was a significant negative 
correlation between age of subjects and eGFR but no significant 
association was observed between eGFR and either systolic or 





The mission of the world kidney day is to raise global awareness of 
the importance of the kidneys to overall health, [11] thereby 
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reducing the frequency of CKD and its attendant burden. 
Population-based education and screening programmes, as were 
carried out in this study, are intended to increase the rates at which 
subjects with kidney disease will be detected, enabling further 
evaluation of those identified and permitting disease modifying 
interventions to be instituted [12]. The risk factors of CKD screened 
for in this population included hypertension, obesity, 
hyperglycaemia, proteinuria, glycosuria as well as eGFR. The 
prevalence of hypertension observed in this study was 20.8%; this 
falls within the range of the overall prevalence of hypertension in 
Nigeria reported to be between 8.0- 46.4% [13]. Ordinioha [14] 
reported a similar prevalence of 21.3% among lecturers in Port 
Harcourt. Similarly a report among civil servants in Kano [15] 
showed a prevalence of 29.8%. Hypertension remains among the 
top three causes of CKD in Nigeria [16,17] and is also a common 
cause of CKD in other parts of Sub-Saharan Africa [1] and when 
uncontrolled, it is known to hasten the progress of CKD as well as 
increase cardiovascular complications. This relatively high 
prevalence of hypertension may be associated with increasing 
urbanization, and adoption of western lifestyle in this environment. 
According to the World Health Organisation (WHO), in 2014, more 
than 1.9billion persons worldwide were overweight and of these 
greater than 600 million were obese.[18] Sub-Saharan Africa is not 
exempt from the obesity epidemic and Abubakari et al [19]in a 
review reported an obesity prevalence of 10% among West African 
adults. In this study, the prevalence of overweight and obesity was 
comparable to that earlier reported in a systematic review among 
adult Nigerians [20]. This relatively high prevalence of overweight 
and obesity observed in this study can be attributed to increased 
popularity in this environment of western diets rich in sugar, 
saturated fats and refined carbohydrates.  
  
There is also an apparent upsurge in the consumption of fast foods; 
this with sedentary lifestyles may encourage the development of 
obesity. The commonest risk factors for CKD remain diabetes and 
hypertension [16,17] and these conditions are known to be strongly 
associated with obesity. Obesity has been shown to have effects 
independently impacting on renal haemodynamics and its tendency 
to cause and/or increase proteinuria may account for its strong 
association with worsening progression of CKD [21,22]. 
Hyperglycaemia in this study was observed in 4.3% of the 
participants, comparable to that observed in other studies.[4,5] In 
Port Harcourt, Nigeria, the prevalence of diabetes was reported to 
be 6.8% among adults [23] and Nigeria is also said to have the 
largest number of people with type 2 diabetes mellitus in Africa 
[24]. Diabetes is also known to be the leading cause of CKD 
worldwide [25] and is gaining an increasing important role as a 
cause of CKD and ESRD in Sub-Saharan Africa [1] and in Nigeria 
[26], therefore this prevalence observed here poses a cause for 
concern. The prevalence of proteinuria in this study was 12.4%. A 
higher prevalence of 19.4% was reported among civil servants in 
Kano [15], while a lower prevalence of 5.6% was observed among 
civil servants in Bayelsa.[4] This high prevalence observed in this 
study is perturbing in this unselected apparently healthy population 
of young people. Proteinuria is an independent risk factor and an 
early indicator of kidney disease and its persistence is known to be 
associated with progression of kidney disease [27]. The prevalence 
of CKD (eGFR< 60mls/min/1.73m2) 1.9% in this cohort was low 
compared to recent reports in Nigeria [4,28]. This is due to the 
relative young study population. Secondly the study is among a 
cohort of University population who are predominantly healthy. It is 
also well known that the eGFR declines with increasing age. This 
study also showed a significant negative correlation between age 
and eGFR. Action taken on subjects in whom risk factors of CKD 
were detected: these subjects were counselled and referred to the 
University Health Centre for further follow up. This study may have 
been limited by its cross-sectional nature (as the participants were 
not screened again to determine if there will be persistence of these 
risk factors), the probable narrow social strata of the study 
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Table 1: clinical and biochemical characteristics of study population 
Variable Total population 









Weight (kg) 68.9±14.2 73.6±13.1 63.8±13.3 0.000 
BMI (kg/m²) 24.7±4.5 24.7±3.9 24.6±5.0 0.794 
SBP (mmHg) 117.3±15.5 121.3±15.8 113.1±14.0 0.000 
DBP (mmHg) 75.7±11.7 78.3±11.5 72.9±11.3 0.000 
eGFR (mls/min) 108.9±29.7 114.9±30.8 102.6±27.2 0.001 









Age(years) -0.231 <0.001 
BMI(kg/m² 0.511 <0.001 
SBP(mmHg) 0.005 0.936 








Figure 1: frequency of risk factors for CKD among the study population 
 
 
 
 
 
